Profile
CTXR VRTX REGN VRNA ARGX ALNY
Company Name Citius Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $8.75M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.02K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Leonard L. Mazur Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
CTXR VRTX REGN VRNA ARGX ALNY
Quant Rating Score 3 4 4 1 4 3
Quant Rating Neutral Buy Buy Strong Sell Buy Neutral
Trading
CTXR VRTX REGN VRNA ARGX ALNY
Last Close $0.9351 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $4.37 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.13 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -78.6 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 619.31 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
CTXR VRTX REGN VRNA ARGX ALNY
1 Month Return -35.51 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -32.73 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 10.22 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -62.14 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -76.62 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 387.54 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CTXR VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -6638184.5 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
CTXR VRTX REGN VRNA ARGX ALNY
Asset Growth 12.25 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth -2.21 % 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth 1.12 % 9.09 % -131.37 % 24.59 %
Net Income Growth 4.36 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 2.06 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 49.66 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share 83.51 % 680.22 % -35.51 % 55.09 %
Operating Income Growth 8.26 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) 5.85 % - -143.33 % -107.98 %
Operating 3 Year CFG 17.6 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 62.99 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG 85.77 % -100 % 40.15 % 97.08 %
EPS Growth 43.38 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth 43.38 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 9.59 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -42.18 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -52.66 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 235.98 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 209.39 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth 5.85 % - -144.48 % -201.54 %
Updated On 30 Sep 2025 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
CTXR VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -28.59 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -57.89 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -44.79 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 96.77 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 100.41 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -1464.35 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.02 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM 0.01 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -1.47 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -1.47 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 23.54 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -1464.35 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.33 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -0.53 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -0.53 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
CTXR VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $-0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.04B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.04B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -3.38 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
CTXR VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.05B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.08B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.13B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
CTXR VRTX REGN VRNA ARGX ALNY
Net Income $-0.04B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $-0.01B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.6
AARD Aardvark Therapeutics, Inc. Common Stock 12.67
ABCL AbCellera Biologics Inc. 3.135
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.06
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.56
ABPWW 0.0133
ABSI Absci Corporation 2.6
ABUS Arbutus Biopharma Corporation 4.16
ABVC ABVC BioPharma, Inc. 1.73
ABVX Abivax SA American Depositary Shares 122.77
ACAD ACADIA Pharmaceuticals Inc. 22.47
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.81
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.28
ACIU AC Immune SA 3.03
ETFs With Exposure to CTXR
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00318 264.95
VTI Vanguard Total Stock Market Index Fund 0 341.47
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00052 151.38
IWN iShares Russell 2000 Value ETF 0.00586 200.55
IWO iShares Russell 2000 Growth ETF 0.00066 339.07
VXF Vanguard Extended Market Index Fund 0.00011 218.1
HDG ProShares Hedge Replication ETF 0.000569059 52.7979
UWM ProShares Ultra Russell2000 0.00113762 53.9
VTHR Vanguard Russell 3000 Index Fund 0 305.97
IWC iShares Micro-Cap ETF 0.02173 168.25
URTY ProShares UltraPro Russell2000 0.000540041 64.75
VTWV Vanguard Russell 2000 Value Index Fund 0.01 176.822
VTWG Vanguard Russell 2000 Growth Index Fund 0 247.625
VTWO Vanguard Russell 2000 Index Fund 0 107.11
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 115
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 114.98
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.53
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.52
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.53
RYLD Global X Russell 2000 Covered Call ETF 0 15.73
VTSAX Vanguard Total Stock Market Index Fund 0 166.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00011 165.55
VITSX Vanguard Total Stock Market Index Fund 0 166.27
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000227224 16.69
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00011 165.56
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00364814 42.85
JKK iShares Morningstar Small-Cap Growth ETF 0.01 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
LOPX Direxion Low Priced Stock ETF 1.42 5.1939
VEMPX Vanguard Extended Market Index InstlPlus 0.00011 408.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 311.9
RSSL Global X Funds 0 103.93
Unlock